Katharine C. Hsu: Featured News

Katharine Hsu and Rosa Sottile
Unusual Immune Cell Type Could Be Good Target for Immunotherapy
Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
Katharine Hsu
Dr. Katharine Hsu Named Director of Tri-Institutional M.D.-Ph.D. Program
In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.
In the Lab
Pictured: Natural Killer Cells & Cancer Cell
Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia
In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.